TL;DR
This study compares two types of stents for treating gastric outlet obstruction (GOO) caused by stomach cancer: individualized stents (custom-shaped) and funnel stents (standardized funnel shape). The findings suggest that funnel stents are as effective as individualized stents in preventing complications like migration and obstruction, while offering a simpler design and production process. This could lead to more accessible and cost-effective treatment options for patients with GOO.
What Problem Does This Paper Address?
Malignant gastric outlet obstruction (GOO) is a serious complication of stomach cancer that significantly impacts a patient's quality of life by preventing them from eating. Endoscopic stent placement has become a primary treatment for GOO, offering palliation when surgery is not an option. However, standard stents have limitations, including a high rate of stent migration and obstruction due to tumor ingrowth or overgrowth, often requiring reintervention. Previous research by the authors showed that individualized stents, designed to match the specific shape of the patient's gastric cavity, could mitigate these issues. This study aims to determine if a simpler, standardized funnel-shaped stent can achieve similar benefits, thereby simplifying the design and production process without compromising clinical outcomes.
Methods
This was a multicenter, controlled, prospective, and randomized clinical trial conducted across four hospitals in China. A total of 88 patients with non-resectable distal gastric cancer and symptomatic GOO were enrolled and randomly assigned to one of two groups:
- Individualized Stent Group (44 patients): Received custom-designed cup and funnel-shaped covered stents, tailored to the specific shape of their proximal gastric cavity.
- Funnel Stent Group (44 patients): Received standardized funnel-shaped covered stents.
The study evaluated several outcome measures, including:
- Technical Success: Successful placement of the stent across the stenosis.
- Clinical Success: Resolution of obstructive symptoms and improvement in dietary intake (defined as a ≥2 grade improvement in the Gastric Outlet Obstruction Score System - GOOSS).
- Shaping Effect: How well the stent conformed to the residual gastric cavity, assessed by endoscopy and barium studies.
- Stent Migration and Obstruction: Incidence of stents moving from their original position or becoming blocked.
- Adverse Events: Complications such as bleeding, perforation, or food impaction.
- Patient Survival: Time from stent placement until death.
Stent design was based on endoscopic assessment of the GOO shape, with measurements of the proximal cavity's breadth and length. The funnel stent design was chosen as the basic consideration due to its simpler production compared to individualized stents.
Datasets
Not discussed in the paper. The study involved patient data collected during the clinical trial.
Key Insights and Ideas
- Simplification is Possible: The core insight is that a standardized funnel stent can achieve comparable clinical outcomes to custom-designed individualized stents for GOO management. This challenges the necessity of complex, patient-specific stent designs in all cases.
- Funnel Shape as a General Solution: The study suggests that the funnel shape, representing a common morphology of proximal gastric cavities in GOO, can be effectively addressed by a standardized funnel stent, simplifying the treatment pathway.
- Improved Patient Outcomes: Both stent types demonstrated high rates of GOO resolution and clinical success, indicating effective palliation. The funnel stent group showed a trend towards better survival, though not statistically significant.
- Cost-Effectiveness Potential: While the direct cost of the stents was comparable, the simpler design and production of funnel stents suggest potential for overall cost reduction in treatment.
Key Results
- GOO Resolution: 100% resolution in the funnel group and 97.7% in the individualized stent group.
- Technical Success: 97.7% in both groups.
- Clinical Success: 97.7% in the individualized stent group and 100% in the funnel stent group.
- Stent Obstruction: Observed in 1 patient in the individualized stent group (tumor ingrowth). No obstruction in the funnel group.
- Stent Migration: Proximal partial migration occurred in 1 patient in each group. No distal migration was observed.
- Shaping Effect: 97.7% in the individualized stent group and 100% in the funnel stent group.
- Survival: Mean survival time was 243±24 days for the individualized stent group and 246±23 days for the funnel stent group.
- Adverse Events: Bleeding occurred in both groups with no statistical difference. No serious adverse events like perforation were reported.
Limitations and Future Work
The authors acknowledge several limitations:
- Funnel Stent Applicability: Funnel stents could only be used for antral strictures and could not be deployed through the endoscopic channel (through-the-scope).
- Covered Membrane Length: The covered membrane length of the funnel stent was not individualized.
- Follow-up Method: Monthly telephone calls for follow-up might have underestimated the rate of stent dysfunction.
Future work could focus on:
- Developing funnel stents that can be deployed through-the-scope.
- Investigating individualized covered membrane lengths for funnel stents.
- Exploring longer-term follow-up strategies to more accurately assess stent performance.
- Further research into the potential cost-effectiveness of funnel stents.
Summary updated